Unprescribed cannabinoids and multiple sclerosis: a multicenter, cross-sectional, epidemiological study in Lombardy, Italy.

Riccardo GiossiMartina MercenariMassimo FilippiChiara ZanettaCarlo Giuseppe AntozziLaura BrambillaPaolo ConfalonieriSebastiano Giuseppe CrisafulliEugenia Tomas RoldanPietro AnnovazziMarta Zaffira ContiCaterina BarrilàMarco RonzoniMonica GrobberioAttilio NegriStefan GustavsenValentina Torri Clerici

Published in: Journal of neurology (2024)

Unprescribed cannabis use is common in patients with MS in Italy, with observed prevalence seemingly superior to the general population, often intended for medical use and without the disclosure to the treating physician, although with potential clinical benefits.

Keyphrases

multiple sclerosis
cross sectional
primary care
emergency department
healthcare
mass spectrometry
risk factors
white matter
ms ms
clinical trial